Evidence map›Paper›PMID 21072305›Full record

ArticleInternational journal of women's health2010

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.

Deirdre R Pachman, Jason M Jones, Charles L Loprinzi

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of women's health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02746497 nacompletednot on this mapstarted 2016, after this paper: background citation

The Efficacy of ACupuncture On Menopausal Symptoms (ACOM): A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of CopenhagenRan2016 to 2017Enrolled70ConditionsMenopauseArmsAcupuncture
NCT02749747 phase3completednot on this mapstarted 2014, after this paper: background citation

Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric: a Double-blind Randomized Clinical Trial

TypeinterventionalSponsorHospital de Clinicas de Porto AlegreRan2014 to 2017Enrolled28ConditionsMenopausal Syndrome, Hot FlashesArmsSulpiride use, Placebo
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Hot flashes: a review.Frontiers in medicine · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Prevalence of menopausal hot flashes in Lebanon: A cross-sectional study.International journal of reproductive biomedicine · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Deirdre R PachmanInternal Medicine, Mayo Clinic, Rochester, MN, USA;
Jason M Jones
Charles L Loprinzi
Mayo Clinic in Arizona · US

Funding

Survivorship research established investigator awardK05CA124477 · NCI · MAYO CLINIC ROCHESTER · PI LOPRINZI, CHARLES L · 2008 to 2012
$777k
NCI NIH HHS K05 CA124477
6 · The paper itself

Abstract

Hot flashes are one of the most common and distressing symptoms associated with menopause, occurring in more than 75% of postmenopausal women. They are especially problematic in breast cancer patients since some breast cancer therapies can induce hot flashes. For mild hot flashes, it is proposed that behavioral modifications are the first step in management. Hormonal therapies, including estrogens and progestogens, are the most well known effective agents in relieving hot flashes; however, the safety of these agents is controversial. There is an increasing amount of literature on nonhormonal agents for the treatment of hot flashes. The most promising data regard newer antidepressant agents such as venlafaxine, which reduces hot flashes by about 60%. Gabapentin is another nonhormonal agent that is effective in reducing hot flashes. While many complimentary therapies, including phytoestrogens, black cohosh, and dehydroepiandrosterone, have been explored for the treatment of hot flashes; none can be recommended at this time. Furthermore, there is a lack of strong evidence to support exercise, yoga, or relaxation for the treatment of hot flashes. Paced respirations and hypnosis appear to be promising enough to warrant further investigation. Another promising nonpharmacological therapy, currently under investigation, involves a stellate ganglion block.

Indexed as

hot flashesmenopausetherapyvasomotor symptoms

Identifiers

PMID21072305
PMCPMC2971731
OpenAlexW2135783033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.